Have a look at the video presentation describing Cynata's Cymerus:
They have just proved this works so there are no expensive trials which could fail; they have a global market; 1st mover advantage; 200 clinical trials underway by their future potential clients; reasonable cash levels; active management looking for big pharma partners in US; only 66m shares on issue; seemingly unlimited blue sky potential.
This seems to me to be a stock which could explode and get caught up in a strong upward trend which feeds itself and is hard to stop. Given that there are only 706 views of this video I think this is still only early days. DYOR.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $46.30M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $27.56K | 141.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79942 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 185380 | 3 |
View Market Depth
| Last trade - 16.14pm 15/09/2025 (20 minute delay) ? |
| CYP (ASX) Chart |